Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
作者信息
Liu Kai, Zhang Wei Han, Hu Jian Kun
机构信息
Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China.
出版信息
Br J Surg. 2022 Jul 15;109(8):e91. doi: 10.1093/bjs/znac129.
Abstract
摘要
相似文献
1
Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.评论：术前化疗及手术后，术后化疗对食管胃腺癌生存情况的影响
Br J Surg. 2022 Jul 15;109(8):e91. doi: 10.1093/bjs/znac129.
2
Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.作者对以下内容的回应：术前化疗和手术后，术后化疗对食管胃腺癌生存的影响。
Br J Surg. 2022 Jul 15;109(8):e92. doi: 10.1093/bjs/znac130.
3
Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.术前化疗和手术治疗后，术后化疗对胃食管腺癌生存的影响。
Br J Surg. 2022 Feb 1;109(2):227-236. doi: 10.1093/bjs/znab427.
4
Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?支持可手术胃癌围手术期化疗的一级证据：是否足以广泛应用于临床？
Ann Surg Oncol. 2007 Oct;14(10):2691-5. doi: 10.1245/s10434-007-9358-z. Epub 2007 Jul 26.
5
Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.围手术期表柔比星、顺铂和卡培他滨化疗在食管癌腺癌切除术中的安全性、疗效及长期随访评估
Ann Surg Oncol. 2015 May;22(5):1555-63. doi: 10.1245/s10434-014-4120-9. Epub 2015 Jan 7.
6
[A Case of Advanced Adenocarcinoma at the Esophagogastric Junction That Exhibited pCR by Preoperative SOX Therapy].[1例经术前SOX治疗达到病理完全缓解的食管胃交界部晚期腺癌]
Gan To Kagaku Ryoho. 2022 Jun;49(6):693-696.
7
Gastro-oesophageal junction: to FLOT or to CROSS?胃食管交界部：选择FLOT方案还是CROSS方案？
Acta Oncol. 2020 Feb;59(2):233-236. doi: 10.1080/0284186X.2019.1698765. Epub 2019 Dec 9.
8
Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.老年局部晚期胃癌和食管胃交界腺癌患者的围手术期化疗：海德堡国家肿瘤疾病中心毒性和疗效的回顾性队列分析
Oncology. 2017;92(5):291-298. doi: 10.1159/000458531. Epub 2017 Mar 2.
9
Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction Cancers.食管癌和食管胃交界癌术前治疗的争议与共识
Surg Oncol Clin N Am. 2017 Apr;26(2):241-256. doi: 10.1016/j.soc.2016.10.009. Epub 2017 Feb 9.
10
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).一项针对HER2阳性伴广泛淋巴结转移的晚期胃癌或食管胃交界腺癌患者，对比单纯全身化疗与联合曲妥珠单抗全身化疗后行手术治疗的随机II期试验：日本临床肿瘤学会研究JCOG1301（触发研究）
Jpn J Clin Oncol. 2015 Nov;45(11):1082-6. doi: 10.1093/jjco/hyv134. Epub 2015 Sep 9.
本文引用的文献
1
Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.术前化疗和手术治疗后，术后化疗对胃食管腺癌生存的影响。
Br J Surg. 2022 Feb 1;109(2):227-236. doi: 10.1093/bjs/znab427.
Zotero 插件